GGrantIndex
← Leaderboards

Garth D. Ehrlich

Allegheny-Singer Research Institute

$17,065,579
Attributed
$17,065,579
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY200519
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$17,065,579 · 8

By mechanism

R01$16,159,688 · 4
P30$903,556 · 1
P41$2,335 · 3

Top collaborators

No co-investigators on record.

Most similar at Allegheny-Singer Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Otitis Media

Research focus

Otitis MediaGene ExpressionGenesGenomeGenomicsHaemophilus InfluenzaeAntibioticsPathogenIn VivoGenome SequencingChildPathogenicityChinchilla (Genus)InfectionBacteriaFundingChronicSourceLibrariesProteomicsTechnologyClinical ResearchHuman SubjectGrant

Grant awards (36)

MetaOmics$438,857
P30 · FY2019 · CA · contact PI
MetaOmics$452,857
P30 · FY2018 · CA · contact PI
MetaOmics$11,842
P30 · FY2018 · CA · contact PI
Molecular Analysis of Pathogens in Otitis Media by PCR$468,764
R01 · FY2017 · DC · contact PI
Molecular Analysis of Pathogens in Otitis Media by PCR$468,764
R01 · FY2016 · DC · contact PI
Molecular Analysis of Pathogens in Otitis Media by PCR$577,678
R01 · FY2015 · DC · contact PI
Molecular Analysis of Pathogens in Otitis Media by PCR$584,219
R01 · FY2014 · DC · contact PI
Molecular Analysis of Pathogens in Otitis Media by PCR$548,173
R01 · FY2013 · DC · contact PI
Molecular Analysis of Pathogens in Otitis Media by PCR$60,010
R01 · FY2013 · DC · contact PI
Impact of Antibiotics and Vaccines on the in vivo Evolution of S. pneumoniae$639,377
R01 · FY2010 · AI · contact PI
SUPRAGENOME ANALYSES OF HUMAN BACTERIAL PATHOGENS$1,091
P41 · FY2010 · RR · contact PI
Impact of Antibiotics and Vaccines on the in vivo Evolution of S. pneumoniae$639,377
R01 · FY2009 · AI · contact PI
Molecular Analysis of Pathogens in Otitis Media by PCR$254,171
R01 · FY2009 · DC · contact PI
SUPRAGENOME ANALYSES OF HUMAN BACTERIAL PATHOGENS$771
P41 · FY2009 · RR · contact PI
The Role of Biofilms in the Pathogenesis of Otorrhea$818,770
R01 · FY2008 · DC · contact PI
Molecular Analysis of Pathogens in Otitis Media by PCR$491,093
R01 · FY2008 · DC · contact PI
SUPRAGENOME ANALYSES OF HUMAN BACTERIAL PATHOGENS$473
P41 · FY2008 · RR · contact PI
The Role of Biofilms in the Pathogenesis of Otorrhea$809,222
R01 · FY2007 · DC · contact PI
Molecular Analysis of Pathogens in Otitis Media by PCR$483,276
R01 · FY2007 · DC · contact PI
The Role of Biofilms in the Pathogenesis of Otorrhea$809,117
R01 · FY2006 · DC · contact PI
Molecular Analysis of Pathogens in Otitis Media by PCR$483,216
R01 · FY2006 · DC · contact PI
The Role of Biofilms in the Pathogenesis of Otorrhea$804,456
R01 · FY2005 · DC
Molecular Analysis of Pathogens in Otitis Media by PCR$489,526
R01 · FY2005 · DC
Role of Biofilms in the Pathogenesis of Otorrhea$793,525
R01 · FY2004 · DC
Molecular Analysis of Pathogens in Otitis Media by PCR$485,305
R01 · FY2004 · DC
GENETICS OF SEVERE PEDIATRIC GASTROESOPHAGEAL REFLUX$401,717
R01 · FY2003 · DC
GENETICS OF SEVERE PEDIATRIC GASTROESOPHAGEAL REFLUX$39,893
R01 · FY2003 · DC
THE ROLE OF BIOFILMS IN THE PATHOGENESIS OF OTORRHEA$1,015,183
R01 · FY2002 · DC
MOLECULAR ANALYSIS OF PATHOGENS IN OTITIS MEDIA BY PCR$373,074
R01 · FY2002 · DC
GENETICS OF SEVERE PEDIATRIC GASTROESOPHAGEAL REFLUX$318,308
R01 · FY2002 · DC
THE ROLE OF BIOFILMS IN THE PATHOGENESIS OF OTORRHEA$986,426
R01 · FY2001 · DC
MOLECULAR ANALYSIS OF PATHOGENS IN OTITIS MEDIA BY PCR$362,496
R01 · FY2001 · DC
GENETICS OF SEVERE PEDIATRIC GASTROESOPHAGEAL REFLUX$318,308
R01 · FY2001 · DC
THE ROLE OF BIOFILMS IN THE PATHOGENESIS OF OTORRHEA$961,999
R01 · FY2000 · DC
MOLECULAR ANALYSIS OF PATHOGENS IN OTITIS MEDIA BY PCR$355,937
R01 · FY2000 · DC
GENETICS OF SEVERE PEDIATRIC GASTROESOPHAGEAL REFLUX$318,308
R01 · FY2000 · DC